Literature DB >> 7621586

Modulation of the IL-1 cytokine network in keratinocytes by intracellular IL-1 alpha and IL-1 receptor antagonist.

W G Phillips1, M Feldmann, S M Breathnach, F M Brennan.   

Abstract

The IL-1 cytokine network in epidermal cells was studied in vitro, using the spontaneously transformed HaCAT human keratinocyte line. Intracellular (ic) IL-1 alpha and IL-1 receptor antagonist protein (IL-1Ra) following cell lysis were readily identified assayed using a capture ELISA; whereas in culture supernatants IL-1Ra was not detected, and IL-1 alpha was present at only very low levels. Confluent cultures of HaCAT cells were shown to provide optimal conditions for the study, since confluence increased the icIL-1Ra:IL-1 alpha ratio to a level as seen in vivo, which was independent of Ca2+ concentration in the culture medium. The IL-1Ra extracted from HaCAT cell lysates was functionally active, as demonstrated in the mouse thymocyte co-proliferation assay which could be blocked using a rabbit anti-IL-1Ra antibody. Transforming growth factor-beta (TGF-beta 1) stimulated a dose-dependent increase in HaCAT cell IL-1 alpha without changing IL-1Ra concentration, with a resultant reduction in the icIL-1Ra: IL-1 alpha ratio from 320:1 to 100:1. Similarly, TGF-alpha, interferon-gamma (IFN-gamma), IL-6, and tumour necrosis factor-alpha (TNF-alpha) substantially increased HaCAT cell IL-1 alpha, but had no effect on the IL-1Ra, with a concomitant reduction in the icIL-1Ra:IL-1 alpha ratio. In contrast to their effects on monocytes, IL-4 and IL-10 at biologically active levels had no effect on IL-1 alpha, IL-1Ra or the icIL-1Ra: IL-1 alpha ratio in confluent HaCAT cells. Hydrocortisone reduced IL-1 alpha to below the limit of sensitivity of the ELISA, and induced a small increase in IL-1Ra of questionable biological significance. Thus, regulation of the IL-1 cytokine network in keratinocytes involves modulation of icIL-1 alpha rather than of icIL-1Ra levels, and is markedly different from that noted in monocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7621586      PMCID: PMC1553310          DOI: 10.1111/j.1365-2249.1995.tb02295.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Glucocorticoid-induced keratinocyte-derived interleukin-1 receptor antagonist(s).

Authors:  S Stosić-Grujicić; M L Lukić
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

2.  Transforming growth factor-beta induces human T lymphocyte migration in vitro.

Authors:  D H Adams; M Hathaway; J Shaw; D Burnett; E Elias; A J Strain
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

3.  Differential modulation of transforming growth factor-beta 1 expression and mucin deposition by retinoic acid and sodium lauryl sulfate in human skin.

Authors:  G J Fisher; A Tavakkol; C E Griffiths; J T Elder; Q Y Zhang; L Finkel; D Danielpour; A B Glick; H Higley; L Ellingsworth
Journal:  J Invest Dermatol       Date:  1992-01       Impact factor: 8.551

4.  Interleukin 1 receptor antagonist in human epidermis and cultured keratinocytes.

Authors:  D Gruaz-Chatellard; C Baumberger; J H Saurat; J M Dayer
Journal:  FEBS Lett       Date:  1991-12-02       Impact factor: 4.124

5.  Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes.

Authors:  K Münger; J A Pietenpol; M R Pittelkow; J T Holt; H L Moses
Journal:  Cell Growth Differ       Date:  1992-05

6.  Identification and induction of keratinocyte-derived IL-10.

Authors:  A H Enk; S I Katz
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

7.  Transforming growth factor-beta differentially regulates the adhesiveness of normal and psoriatic dermal microvascular endothelial cells for peripheral blood mononuclear cells.

Authors:  J P Cai; V Falanga; J R Taylor; Y H Chin
Journal:  J Invest Dermatol       Date:  1992-04       Impact factor: 8.551

8.  Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways.

Authors:  J Reibman; S Meixler; T C Lee; L I Gold; B N Cronstein; K A Haines; S L Kolasinski; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

9.  Interleukin-1 receptor antagonist production by human keratinocytes.

Authors:  C F Bigler; D A Norris; W L Weston; W P Arend
Journal:  J Invest Dermatol       Date:  1992-01       Impact factor: 8.551

Review 10.  Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.

Authors:  W P Arend
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

View more
  7 in total

1.  Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.

Authors:  C Gabay; M F Smith; D Eidlen; W P Arend
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

2.  IL-1ra and IL-1 production in human oral mucosal epithelial cells in culture: differential modulation by TGF-beta1 and IL-4.

Authors:  S Perrier; B Kherratia; C Deschaumes; S Ughetto; J-L Kemeny; M Baudet-Pommel; B Sauvezie
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

3.  Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin.

Authors:  Daryle Depianto; Michelle L Kerns; Andrzej A Dlugosz; Pierre A Coulombe
Journal:  Nat Genet       Date:  2010-09-26       Impact factor: 38.330

4.  Inflammasome involvement in CS-induced damage in HaCaT keratinocytes.

Authors:  Roxane Prieux; Francesca Ferrara; Franco Cervellati; Anna Guiotto; Mascia Benedusi; Giuseppe Valacchi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2022-04-15       Impact factor: 2.723

5.  Interleukin-1α Induction in Human Keratinocytes (HaCaT): An In Vitro Model for Chemoprevention in Skin.

Authors:  T Magcwebeba; S Riedel; S Swanevelder; P Bouic; P Swart; W Gelderblom
Journal:  J Skin Cancer       Date:  2012-06-25

6.  Syk/Src pathway-targeted inhibition of skin inflammatory responses by carnosic acid.

Authors:  Jueun Oh; Tao Yu; Soo Jeong Choi; Yanyan Yang; Heung Soo Baek; Soon Ae An; Lee Kyoung Kwon; Jinsol Kim; Ho Sik Rho; Song Seok Shin; Wahn Soo Choi; Sungyoul Hong; Jae Youl Cho
Journal:  Mediators Inflamm       Date:  2012-04-10       Impact factor: 4.711

Review 7.  IL-1/IL-1R Signaling in Head and Neck Cancer.

Authors:  Sven E Niklander; Craig Murdoch; Keith D Hunter
Journal:  Front Oral Health       Date:  2021-08-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.